Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06258707Not ApplicableRecruiting

Bicentric Clinical Investigation to Assess Safety and Performance of LuxBoost IOL

Role: lead

NCT06105190Not ApplicableActive Not Recruiting

Clinical Study to Evaluate Clinical Outcomes of LuxSmart IOL as Compared With LuxGood IOL

Role: lead

NCT06446817Not ApplicableRecruiting

Bicentric Clinical Investigation to Assess Safety and Performance of LuxHighAdd IOL

Role: lead

NCT04465344Not ApplicableCompleted

Multicentric Clinical Study on Isatis TF Trifocal Intraocular Lens

Role: lead

NCT05561478Recruiting

Comparison of Visual Outcomes After Implantation of the Synthesis Plus and Synthesis Plus Toric

Role: lead

All 5 trials loaded